EUR 217.8
(2.16%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 2.36 Billion USD | 9.68% |
2023 | 2.15 Billion USD | 16.44% |
2022 | 1.85 Billion USD | 26.33% |
2021 | 1.46 Billion USD | 32.7% |
2020 | 1.1 Billion USD | 28.05% |
2019 | 862.21 Million USD | 25.77% |
2018 | 685.57 Million USD | 26.01% |
2017 | 544.04 Million USD | 32.95% |
2016 | 409.22 Million USD | 30.65% |
2015 | 313.22 Million USD | 49.05% |
2014 | 210.15 Million USD | 62.22% |
2013 | 129.54 Million USD | 111.47% |
2012 | 61.26 Million USD | 110.31% |
2011 | 29.12 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 FY | 2.36 Billion USD | 9.68% |
2024 Q3 | 616.5 Million USD | 4.45% |
2024 Q1 | 526.32 Million USD | -6.58% |
2024 Q2 | 590.22 Million USD | 12.14% |
2024 Q4 | 630.61 Million USD | 2.29% |
2023 FY | 2.15 Billion USD | 16.44% |
2023 Q3 | 552.35 Million USD | 3.39% |
2023 Q4 | 563.38 Million USD | 2.0% |
2023 Q1 | 505.1 Million USD | 4.04% |
2023 Q2 | 534.21 Million USD | 5.76% |
2022 Q1 | 433.57 Million USD | 9.28% |
2022 FY | 1.85 Billion USD | 26.33% |
2022 Q4 | 485.49 Million USD | 1.97% |
2022 Q3 | 476.11 Million USD | 4.5% |
2022 Q2 | 455.59 Million USD | 5.08% |
2021 Q4 | 396.76 Million USD | 5.1% |
2021 Q2 | 353.68 Million USD | 4.92% |
2021 Q3 | 377.51 Million USD | 6.74% |
2021 FY | 1.46 Billion USD | 32.7% |
2021 Q1 | 337.1 Million USD | 8.22% |
2020 Q3 | 280.92 Million USD | 5.25% |
2020 Q1 | 244.75 Million USD | 5.35% |
2020 Q4 | 311.5 Million USD | 10.89% |
2020 FY | 1.1 Billion USD | 28.05% |
2020 Q2 | 266.9 Million USD | 9.05% |
2019 Q4 | 232.32 Million USD | 3.38% |
2019 Q3 | 224.73 Million USD | 7.21% |
2019 Q2 | 209.6 Million USD | 7.19% |
2019 FY | 862.21 Million USD | 25.77% |
2019 Q1 | 195.54 Million USD | 5.75% |
2018 Q3 | 176.14 Million USD | 5.74% |
2018 FY | 685.57 Million USD | 26.01% |
2018 Q4 | 184.91 Million USD | 4.98% |
2018 Q2 | 166.58 Million USD | 5.49% |
2018 Q1 | 157.91 Million USD | 5.17% |
2017 Q2 | 131.34 Million USD | 9.67% |
2017 FY | 544.04 Million USD | 32.95% |
2017 Q4 | 150.15 Million USD | 5.16% |
2017 Q3 | 142.77 Million USD | 8.7% |
2017 Q1 | 119.76 Million USD | 4.81% |
2016 Q1 | 89.92 Million USD | 3.35% |
2016 FY | 409.22 Million USD | 30.65% |
2016 Q4 | 114.27 Million USD | 6.87% |
2016 Q3 | 106.92 Million USD | 8.98% |
2016 Q2 | 98.1 Million USD | 9.1% |
2015 Q2 | 75.66 Million USD | 13.4% |
2015 Q3 | 83.82 Million USD | 10.79% |
2015 Q1 | 66.72 Million USD | 6.24% |
2015 FY | 313.22 Million USD | 49.05% |
2015 Q4 | 87.01 Million USD | 3.8% |
2014 Q3 | 54.97 Million USD | 10.89% |
2014 Q4 | 62.8 Million USD | 14.23% |
2014 Q2 | 49.58 Million USD | 15.88% |
2014 FY | 210.15 Million USD | 62.22% |
2014 Q1 | 42.78 Million USD | 7.54% |
2013 Q3 | 35.79 Million USD | 0.0% |
2013 Q4 | 39.78 Million USD | 11.15% |
2013 FY | 129.54 Million USD | 111.47% |
2012 FY | 61.26 Million USD | 110.31% |
2011 FY | 29.12 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
DocCheck AG | 53.41 Million EUR | -4325.137% |
CompuGroup Medical SE & Co. KGaA | 1.18 Billion EUR | -99.019% |
MeVis Medical Solutions AG | 17.34 Million EUR | -13529.8% |
Nexus AG | 241.45 Million EUR | -878.913% |